It will be fun to post the links to all your BS and predictions you have posted which have been 100% inaccurate . But don’t have time for that

Here is one for you also
Ignorance is bliss
Stay blissful

I have watched and listened here for a decade . Mother of all short squeezes and what not .
Thanks for your advice . But I like to listen to my own intuition now

Well there were zero reported in Jan- July report . And report’s heading is Jan- Aug from a month ago , and Jan- Sept for the current report implying it is cumulative number .

It clearly says % granted in stipulated timeline , means the remaining percent left were granted in more than stipulated timeline . It doesn’t include the applications which are not granted and still pending .

Where do you get 9 applications
They are only reporting the time met or not on granted applications
That is Jan - Aug - 2 granted with 50% within stipulated time ( so one out of two)
In Jan - Sep report , 1 additional granted , so total granted = 3 . As total went from 2 to 3, percent granted within timeline went from 50 to 33% implying the only one they granted was not within timeline .
How would granted in stipulated timeline drop from 50% to 33% otherwise with only 1 granted in September .

I think it means out of 3 only 1 was in stipulated time . If you look at 1 month older report it was 2 granted and meeting stipulated time 50% of the time (1 out of 2 granted) . So it makes sense since the number of granted went from 2 to 3 , percentage meeting dropped from 50 to 33 percent because the only new one they approved in Sept didn’t meet timeline .

.30 has become resistance instead of support as I said last week . It is quite obvious now .

Thanks Stonk
Quite dismal still
Only three granted From Jan - Sept ( in 9 months ) . Moreover they were meeting the stipulated timeline 50% of the time in Sept report ( so 1 out of 2 granted) . Now it has dropped to 33%( so two out of the three initial MAA’s granted this year were more than stipulated timeline).
But they won’t tell how many days above the timeline for obvious reasons .
So doesn’t real mean much , they could determine NW application this month in 1-2 months or early next year . Still a guess .

They could have done that when they spun Advent off of Cognate , when they were required to distance themselves from Cognate . Why would they do it now .

Don’t take it personally . It’s his job .

Lol
Popping to reply to every post so not to miss any chance to be an apologist to report to whoever you report that you are doing the job .
Yep everyone can easily see your “occasional” “ pop ins” . Every can easily decide for themselves what ever that means . No need for me to explain.
But I like the popping sound . Carry on

Lol
You were posting whole weekend as well
And you were here later than me last night and up around same time as me today
It does give few good laughs reading your frustrated posts early in morning
Very amusing

Not sure if this had been shared here in the past . It’s couple of years old . Just came across it

https://www.regulations.gov/document/FDA-2019-D-4964-0071

Lol
After lecturing others that ChatGPT is unreliable , I guess your job demanded that you do the same .
Very amusing

So you posted after me . So who “is still working even later” . But logic has never been your forte .
But I do understand you have your memo/orders to follow because SP is going down , so workin later is understandable .

Do carry on

He don’t like facts

BS

Most reasonable people clearly understood the context of my post except very few who would like to put positive spin on everything

He just replied to my post that NWBO gives timely quarterly updates to shareholders . You don’t need to engage with him . Everyone clearly knows his motives

Which quarterly conference calls and Q&As ??

Articles haven’t affected the share price in either direction in years - both AF/street and SOS .
Only major movement will be from a significant news . Not from the articles, or posts on a message board or MTD . News that shows the market financial stability and path towards significant financial reserve and commercialization , and end of unabated dilution at pennies per share .

Maybe stop loss triggers . As I said last week it’s possible this will keep dripping down slowly to next support level . As I said this AM also 1/2 to 1 cent drop every 2-3 days on average is possible and would have been typical till the support is reached without news . But pending MHRA decision is uncertainty in the mix , because of which it’s hard to say how this will go .

Hmm sure
Whatever makes you happy and gets you the fuzzy feeling knowing that every thing that happens is some one else’s fault

Lol
They live in alternate universe , where one celebrates every time we hit new low , because it’s an opportunity , while one never gets opportunity to actually sell at high and realize any meaningful gains .
And every time it goes down , longs are celebrating and shorts are running scared .
You really can’t make it up even if you tried to.

There are select few who defend every action , inaction , decision 24/7 here and have had ABSOLUTELY ZERO criticism over last decade . That implies everyone in company is PERFECT , incapable of making any bad or wrong decision . “Perfection personified “ so to speak .
So their incentive and motive to post such is always suspect to me .

You can believe what you want . All my price predictions for last 1 year have been mostly true
I also predicted Sunday evening after ASM how market will react , when usual few were cheerleading, and it is exactly how it reacted Monday and days after. But you can believe in your mind what you want , it doesn’t change the reality .

Volume doesn’t point of any leak
As per my previous posts , and also from last week , it is following natural course without news . There just isn’t long term support in mid and high .20s . Likely will be half to 1 cent decline every couple of days till next support level. Usual few will post all kind of blames and badmouth the rest . Hopefully possibility of approval news in next few weeks may help diminish that or get it past .30 resistance . But we will have to wait and see .

Well you were doing that job I think . You brought it down from $12 to 0.25 .
Great job . Please do weekly or daily predictions .

Says Newman 10000th time , with success rate of 0.0

He is known for going into hiding when shown facts and also his own posts from the past .

“No volume”

Maybe relearn counting

That what is said at SIO raise also when usual few were touting approval soon

As I said last week there is no support in mid .20s or high .20s and I predicted this to happen . Volume is not high enough to suggest big leak

SP is partly down because no one cares or wants your shares

Wait for usual few like DD, bio etc to put a positive spin to it

Agree
Read the contracts with cognate . How many millions were being paid to cognate several years to almost a decade ago to be production ready .

But I forgot , it is considered a good thing in NW universe , because this is management giving “another” , “very very last opportunity “ to buy on the low as a gift to faithful longs .

As expected and predicted .30 is now resistance . And fact that there is no long term support in mid and high .20s as I said last week also will be tested soon .

And don’t forget it was Cognate before that and how much was it sold for . Advent was part of cognate and was spun off of cognate when the related party transaction issue arose and they had to distance from cognate . You can read previous SECs etc .

All companies I have invested including bio’s have had quarterly reporting/updates , engaged CEOs . And have never seen as many. blind followers except maybe in Tesla . Any deviation from above is usually exception and not norm .

As usual you will get a lecture how you are not mature enough or savvy enough to invest in de stage biotech . If a company after close to 30 years since inception remains in dev stage with one product , it is stupidity of investors who were not smart enough to invest . Although some of us have invested in other biotech companies as well .


“Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton.”